Spore.Bio, a Paris-based deeptech company, today announces a major multi-million dollar funding from the Google.Org Fund for AI in Science, and the launch of Spore.Labs, a new fundamental AI-native research division to tackle the most pressing challenges in Public Health.
Following the recent award to Demis Hassabis and John Jumper of the Nobel Prize (® the Nobel Foundation) in Chemistry, for AlphaFold’s contributions to protein structure prediction, Google.org announced the creation of a major fund to support academic and nonprofit organizations around the world that are using AI to address increasingly complex problems at the intersections of different disciplines of science.
Spore.Bio is the only startup in the world selected by the Google.org AI for Science Fund to tackle this challenge, placing the company at the forefront of global efforts in Public Health and giving major resources to fight the microbial challenges of the Twenty-First Century.
Spore.Labs represents a new model for microbiology research, bringing together AI researchers, microbiologists, and photonics engineers in a collaborative environment designed to unlock fundamentally new understanding of microbial behavior. By combining advanced biophotonics with machine learning, the platform captures and analyzes how micro-organisms behave, evolve, and develop resistance at unprecedented resolution and speed.
Spore.Labs’ research will drive innovations in diagnostic technologies, industrial biomonitoring, and environmental health applications, with the potential to transform how we detect and respond to microbial threats. By making microbial testing faster, more accurate, and intelligence-driven, the lab's work promises to accelerate breakthroughs that protect public health and industrial safety.
"Spore.Labs embodies our vision of what microbiology research should look like in the AI era," said Amine Raji, CEO of Spore.Bio. “With support from Google.org, we're creating a research environment where the boundaries between biology, physics, and computer science dissolve, allowing us to see and understand microbes in ways that were previously impossible."
With consequent funding and Google Cloud Platform credits from Google.org, Spore.Labs will develop open datasets, publish research findings, and collaborate with academic and clinical partners to validate its approaches. The lab has opened 15 scientists positions in Microbiology, Photonics and Deep Learning, and will hire 30 scientists by the end of 2026.
About Spore.Bio
Spore.Bio is a Paris-based biotech company transforming microbiology through the convergence of photonics, hardware engineering, and artificial intelligence. The company develops intelligent full stack platforms that enable industries and healthcare systems to monitor and understand microbial life with unprecedented speed, accuracy, and insight. By making microbial testing faster, more reliable, and data-driven, Spore.Bio's technology contributes to safer products, cleaner environments, and more resilient public health systems. Spore.Bio has raised 35M$ to date.
About the Google.org AI for Science Fund
The Google.org AI for Science Fund is a multi-million initiative supporting organizations at the forefront of AI-driven scientific discovery, awarding grants to academic institutions, nonprofit and for-profit organizations worldwide applying artificial intelligence to solve complex challenges across scientific disciplines.
